Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Half Yearly Report

24th Sep 2009 07:00

RNS Number : 5693Z
Acta S.p.A.
24 September 2009
 



24 September 2009

Acta S.p.A

Interim Results for the six months ended 30 June 2009

Acta, the catalyst technology development company, today announces its interim results for the six months ended 30 June 2009.

Financial Highlights

Operating loss significantly reduced to €1.4 million (1H 08: €3.1 million)

€717,000 Italian grant income recognised, including €212,000 new grant approved for prior R&D costs

Net cash outflow €1.0m (1H 08: €0.9inflow including €2.9m capital increase)

Period end cash position €5.4m (1H 08: €8.8m)

Commercial Highlights:

Development of Acta Energy business division and commercial opportunities

Trade show launch of water electrolyser for low cost, high pressure hydrogen generation

Second stage of development contract with major Asian manufacturer and Sumitomo completed on time 

Outlook:

Commercial launch of Acta Energy business activities

Hydrogen generator on schedule for 2009 market testing and 2010 product launch

Continued tight control of overhead costs and prioritisation of near-term commercial opportunities 

Additional development contract and grant funding expected to be received in second half. New grant opportunities being pursued.

Capital expenditure and working capital investments focused on short term cash generation 

Robert Drummond, Chairman, said today:

"While financial markets have started to show recovery, the wider economic outlook remains uncertain, and we believe that research and development budgets within our customer base will remain under pressure for the medium term. Over the last year Acta has responded purposefully to this change of environment, shifting its business focus to near-term commercial and product opportunities, while reducing costs and conserving cash.

Over the next six months the fruits of this strategy will become increasingly evident through the launch of the Acta Energy business and its renewable energy product rangesupported by the launch of our domestic hydrogen generation unit. This highly innovative new product continues to beat our expectations in terms of high performance and low cost, and we believe that it has significant commercial potential as a recharger of mid-sized fuel cell consumer products.

Acta will continue to pursue its advanced catalyst applications, including specialised ammonia cracking catalysts and catalysts for zinc-air batteries, with major industrial customers. We expect activity in these longer term areas to pick up again as economic conditions improve."

- Ends -

  For further information please contact:

Acta S.p.A:

Paul Barritt, Chief Financial Officer

Tel: +39 050 644281

Charles Stanley Securities (Nominated Adviser):

Tel: +44 (0) 20 7149 6000

Russell Cook / Freddy Crossley 

Notes to Editors

About Acta 

Acta develops and manufactures unique patented catalysts which have been launched to the renewable energy, automotive, battery and industrial markets. Acta is also developing other commercial opportunities using its catalysts for industrial waste treatment.

Acta's catalysts and alkaline system know-how are at the heart of the Company's development of a new, high pressure water electrolyser technology which has demonstrated low cost, platinum free, high pressure hydrogen generation. Combined with a platinum free fuel cell, the system offers a solution to the problem of how to store surplus energy produced from large scale, intermittent renewable energy sources (eg wind farms).

Acta's catalysts are also undergoing customer tests in applications such as ammonia treatment (removal of ammonia from an industrial waste stream), and zinc-air batteries (a high performance and environmentally friendly battery technology), as well as fuel cell and other applications.

  Chairman's Statement

Acta has made substantial progress during the first half of 2009, despite the difficult economic environment.

Of particular commercial significance has been the continuing successful development of our hydrogen generation technology (alkaline membrane water electrolyser). This device allows the domestic production of safe, low cost, high-pressure hydrogen, which is generated at a sufficient level of quality (purity and dryness) for direct recharging of mid-sized consumer fuel cell applications.

We see this product as a key enabling technology which will facilitate commercial opportunities for ourselves and others both upstream (domestic and industrial renewable energy generation) and downstream (mid-sized fuel cell products). The positioning of the product as an entry point to the industrial electrolysis market is also particularly encouraging. A new division, Acta Energy, is being formed to capture these opportunities, and is developing a number of commercial partnerships to accelerate our progress.

During the first quarter, as announced on 26 March 2009, we successfully completed the second stage of our development contract with a major Asian manufacturer and Sumitomo. We also announced that the Company had received approval for the €12m government grant-funded Hydrostore project, under which Acta will receive €750,000 over a three-year period to scale up its hydrogen generation technology for electricity grid management applications, together with ENI, ENEL and other partners. These applications address very large potential markets in the medium to long termand within our product portfolio strategy they provide a balance to our current focus on near-term opportunities.

Technical progress continues on our other key applications, such as advanced battery technology and ammonia waste treatment. We have also continued to pursue new grant funding both in Italy and elsewhere to support our activities, and in June Acta's application for a €212,000 Italian government contribution to prior research and development costs was approved, which will benefit cash flow during the second half.

Our cost reduction programme, commenced in Autumn 2008, has produced important savings, contributing to a reduction in first half operating losses from €3.1m (1H 08) to €1.4m, after recognising grant income of €717,000 in the current period. We believe this to be an appropriate cost base for our current activities and that the savings will enable Acta to extend its cash resources well into 2011.

Commercial Progress

In February 2009 Acta demonstrated the prototype of its hydrogen generator at the Fuel Cell Expo in Tokyo. The commercial and technical interest shown in the product indicated its potential to enable market acceptance of the many consumer fuel cell applications that were on display at the same show. This encouraged us to accelerate the technical development of the product, and in particular compact unit for the domestic market, and we are now pursuing the wider commercial opportunities that we expect this product to generate.

The non-captive market for hydrogen production is estimated to be worth $13 billion per annum, and to be growing at 10% per annum (Source: Arno Evers, Dec 08). We believe that the low entry price and technical merits of our hydrogen generator will allow us address the market demand for small electrolyser systems, where mainstream electrolyser technologies cannot compete with cylinder-delivered hydrogen for reasons of cost and system footprint. In addition, we believe that significant opportunities exist in the demand for fuel cell systems, including battery-substitute applications (eg UPS systems) and consumer fuel cell applications, which can bundled together with our hydrogen generator.

The wider opportunities arising from Acta's hydrogen generator also include solar panel installations, where the Italian market, currently one of the most active in Europe, has previously been under-invested and is now benefitting from prime site availability, high government incentives and a strong reduction in the price of solar panels. We are developing partnerships to pursue these opportunities through Acta Energy, to enable hydrogen generation direct from intermittent renewable power sources.

We anticipate the full commercial launch of the Acta Energy business division within the first half of 2010, led by initial orders for the hydrogen generator and associated fuel cell products over the next six months.

Technical Progress

In addition to the significant effort dedicated to the development of the water electrolyser, Acta has continued to make good technical progress in the development of advanced catalysts for generating hydrogen from ammonia by reforming (using catalysts and heat to break down ammonia into hydrogen and nitrogen). Our benchmark tests indicate that these catalysts perform far better than existing comparable catalysts, while being free of precious metals and therefore capable of supply for very large scale applications.

Furthermorethe results of testing our zinc-air battery catalysts by a major US customer have been encouraging, leading to a larger sample order for the catalyst which is now being studied for possible inclusion in a US Dept of Defence research project. We have also undertaken further developments in hydrogen-air fuel cell components.

Intellectual Property Development

Acta filed three new patent applications in the first half of the year, and a further two after the period end, including one application for a European patent extension (PCT). The Company's intellectual property portfolio now contains patent applications covering 28 separate intellectual property claims. 

Operational Progress

Acta has maintained its internal operational capabilities during the year to date despite the cost savings achieved, by focusing these savings on external services and non-core activities. In addition Acta is developing supply, subcontract manufacturing and distribution partnerships in preparation for the launch of the hydrogen generator and Acta Energy. These partnerships will maximise the commercial potential of the hydrogen generator and associated products, without unduly burdening the internal resources or overhead base of the Company.

Financial Performance

Acta incurred an operating loss of €1.4m in first half of 2009, down from €3.1m in the six months to June 2008Revenues during the first half were €275,000 (1H 08: €360,000), mainly arising from the second stage of our development contract with Sumitomo Corporation and a major Asian manufacturer, announced in November 2008.

Grant income of €717,000 was recognised in the period relating to prior research and development costs (1H 08: €119,000). Of this income, €505,000 was recognised in relation to the €2.1 million FIT project (development of a prototype direct ethanol fuel cell stack) whicwas concluded in the second half of 2008; and €212,000 was recognised in relation to a new Italian government tax contribution scheme for research and development costs which was approved in June 2009. 

The reduction in operating losses to €1.4m reflects the impact of grants recognised in the period, the cost for which have been expensed in prior period, and a reduction in operating costs of €945,000, including stock option costs and other non-cash items. Following the cost reduction programme initiated in 2008, total cash savings in operating costs are expected to be approximately €1.0m for the year.

Net cash utilisation for the period, at €1.0m (1H 08: €2.0m excluding capital increase), was below operating losses, and cash and short term investments stood at €5.4m as at 30 June 2009 (1H 08: €8.8m). €755,000 was received as low-interest bearing loan in relation to the FIT grant project during the period (1H 08: €119,000 grant income received), and investments in technical equipment, patents and other capital items were reduced sharply to €71,000 (1H 08: €242,000). At current cash utilisation rates the Company will have sufficient funds well into 2011.

Business Outlook 

We look forward to moving into full commercial operations over the next year as our near-term product developments and commercial opportunities come to fruition. We will be working with partners where possible to bring expertise and relationships that can accelerate our time to market.

We believe that the trade launch of our simple, low-cost, high pressure hydrogen generator will attract significant interest, and we are hopeful that, aside from established commercial and industrial applications, it will become part of the solution that will finally bring fuel cell products and applications to the consumer market.

External research and development expenditure by major corporations is expected to stay subdued over the next year, and consequently our development contract revenues and timeframes may remain uncertain. We will stay cautious in our expenditure and investments over this period, and will continue to dedicate our resources to those products and opportunities which, while coherent with our business strategy, can provide near-term commercial revenues and routes to promising market opportunities.

Acta continues to exploit its leadership in platinum-free catalysis and alkaline membrane systems with major customers and supply chain partners, and will continue to pursue the development of major industrial applications for its catalysts.  

We believe that the next phase of the company's development will provide greater evidence of the depth and commercial potential of our technologies, and we look forward to updating shareholders on commercial progress in due course.

Robert Drummond

Non Executive Chairman

  

Consolidated income statement

Six months ended

Six months ended

Year ended

30 June 2009

30 June 2008

31 December 2008

Unaudited

Unaudited

Audited

€'000

€'000

€'000

Revenue

 275 

 360 

 625 

Raw materials and consumables used

(93)

(205)

(352)

Personnel expense

(1,427)

(2,092)

(3,560)

Depreciation and amortisation expense

(212)

(193)

(400)

Other operating expenses 

 58 

(931)

(1,758)

Loss from operations

(1,399)

(3,061)

(5,445)

Financial income

 85 

 129 

 317 

Financial expenses

(20)

(20)

(57)

Loss before tax

(1,334)

(2,953)

(5,185)

Current tax credits

 3 

 

 

 

Loss for the period

(1,334)

(2,953)

(5,182)

Attributable to:

Equity holders of the parent

(1,387)

(2,890)

(5,072)

Minority interest

 53 

(63)

(110)

(1,334)

(2,953)

(5,182)

Basic and diluted earnings per share (euro)

(0.03

(0.07

(0.13) 

  

Consolidated balance sheet

Six months

 ended

Six months ended

Year ended

30 June 2009

30 June 2008

31 December 2008

Unaudited

Unaudited

Audited

ASSETS

€'000

€'000

€'000

Non-current assets

Property, plant and equipment

 1,793 

1,945 

1,919 

Goodwill

 11 

11 

11 

Intangible assets

 797 

842 

813 

Total non-current assets

 2,601 

2,798 

2,743 

Current assets

Inventories

 63 

64 

63 

Available for sale financial instruments

 3,498 

3,493 

3,520 

Trade and other receivables

 1,183 

402 

619 

Cash and cash equivalents

 1,942 

5,316 

2,925 

Total current assets

 6,686 

9,275 

7,127 

Total assets

 9,287 

12,073 

9,870 

EQUITY AND LIABILITIES

Equity attributable to equity holders of the parent 

Share capital

 246 

246 

246 

Capital reserves

 25,914 

25,739 

25,802 

Retained losses

(20,374)

(16,651) 

(18,829) 

 5,786 

9,333 

7,219 

Minority interest

 61 

57 

Total equity

 5,847 

9,390 

7,227 

Non-current liabilities

Employee benefits

 110 

97 

112 

Long-term provisions

 526 

89 

526 

Long-term borrowings

 1,626 

898 

854 

Total non-current liabilities

 2,262 

1,085 

1,492 

Current liabilities

Other financial liabilities

 57 

57 

57 

Short-term borrowings

 46 

48 

75 

Trade and other payables

 1,075 

1,494 

1,019 

Total current liabilities

 1,178 

1,599 

1,151 

Total liabilities

 3,441 

2,683 

2,643 

Total equity and liabilities

 9,287 

12,073 

9,870 

  

Statement of changes in equity

Share

Reserve

Retained

Group

Minority

Total

Capital

Capital

Earnings

Total

Interest

€'000

€'000

€'000

€'000

€'000

€'000

At 1 January 2008

 234 

 22,380 

(13,762)

 8,852 

 120 

 8,972 

Issue of share capital

 12 

 2,896 

 2,908 

 2,908 

Foreign Currency Translation Reserve 

(35)

(35)

(35)

Share issue expenses

(6)

(6)

(6)

Net change in fair value available for sale

 26 

 - 

 26 

 - 

 26 

other movements

 5 

 5 

(2)

 3 

Share-based payment

 541 

 541 

 541 

Loss for the period

(5,072)

(5,072)

(110)

(5,182)

At 31 December 2008

 246 

 25,802 

(18,829)

 7,219 

 8 

 7,227 

At 1 January 2008

 234 

 22,380 

(13,762)

 8,852 

 120 

 8,972 

Issue of share capital

 12 

 2,903 

 2,915 

 2,915 

Share issue expenses

-

(6)

-

(6)

-

(6)

Share-based payment

-

 462 

-

 462 

-

 462 

Loss for the period

-

-

(2,890)

(2,890)

(63)

(2,953)

At 30 June 2008

 246 

 25,739 

(16,652)

 9,333 

 57 

 9,390 

At 1 January 2009

 246 

 25,802 

(18,829)

 7,219 

 8 

 7,227 

Foreign Currency Translation Reserve 

 34 

(157)

(123)

(123)

Net change in fair value available for sale

(22)

 - 

(22)

 - 

(22)

Share-based payment

 100 

 100 

 100 

Loss for the period

(1,388)

(1,388)

 53 

(1,335)

At 30 June 2009

 246 

 25,914 

(20,374)

 5,786 

 61 

 5,847 

  

Consolidated cash flow statement

Six months ended

Six months ended

Year ended

30 June 2009

30 June 2008

31 December 2008

Unaudited

Unaudited

Audited

Cash flows from operating activities

€'000

€'000

€'000

Loss for the year

(1,334)

(2,953) 

(5,182) 

Adjustments for:

Depreciation

 142 

127 

264 

Amortisation of intangible assets

 70 

67 

136 

Allowance for future risks

437 

Gain on sale of property, plant and equipment

18 

Expense recognised in profit or loss in respect of share based payments

 100 

462 

541 

Foreign Currency Translation Reserve 

(123)

(35) 

Net finance income

(65)

(108) 

(260) 

Movements in working capital

(Increase) decrease in trade and other receivables

(564)

566 

348 

(Increase) decrease in inventories

10 

11 

Increase (decrease) in trade and other payables

 56 

(79) 

(554

Increase (decrease) in provision for employees' benefits (TFR)

(2)

35 

50 

Cash outflow from operations

(1,720)

(1,874) 

(4,226

Interest paid

(20)

(21) 

(57) 

 

Net cash from operating activities

(1,740)

(1,895) 

(4,283

Cash flows from investing activites

Interest received

 85 

129 

317 

Payments for property, plant and equipment

(17)

(211) 

(326) 

Proceeds from sale of property, plant and equipment

-

-

(11) 

Payments for intangible assets

(54)

(31) 

(71) 

Finance leases

 23 

Net cash used in investing activities

 37 

(113) 

(82) 

Cash flows from financing activities

Proceeds from issue of share capital

2,915 

2,908 

Payment for share issue costs

(6) 

(6) 

Proceeds from borrowings

 740 

-

-

Repayment of borrowings

(27) 

(17) 

Payment of finance lease liabilities

(20)

(37) 

Net cash inflow from financing activities

 720 

2,882 

2,848 

Net increase in cash and cash equivalents

(983)

874 

(1,517

Cash and cash equivalents at the beginning of the financial year

 2,925 

4,442 

4,442 

Cash and cash equivalents at the end of the financial year

 1,942 

5,316 

2,925 

  

Notes to the interim financial statements

for the six months ended 30 June 2009

1. Basis of preparation

The financial statements have been prepared using accounting policies consistent with International Financial Reporting Standards and in accordance with International Accounting Standard (IAS) 34 Interim Financial Reporting.

2. Principal accounting policies

The financial statements have been prepared under the historical cost convention. The same accounting policies, presentation and methods of computation are followed in these financial statements as were applied in the preparation of the Group's financial statements for the year ended 31 December 2008.

3. Loss per share

The calculation is based on information in the table shown below:

Six months ended 30 June 2009

Six months ended 30 June 2008

Year ended 31 December 2008

(unaudited)

(unaudited)

(audited)

€'000

€'000

€'000

Loss 

(1,334)

(2,953) 

(5,182) 

Weighted average number of shares

40,995,125

38,778,687 

40,518,413

In accordance with IAS 33.41, the potential ordinary shares have not been treated as dilutive because their conversion to ordinary shares would decrease loss per share for the period.

4. Statement of changes in equity

Share

Capital 

Retained 

Minority 

capital

Reserve

earnings

Interest

Total

€'000

€'000

€'000

€'000

€'000

Balance at 1 January 2008

234 

22,380 

(13,762) 

120 

8,972 

Issue of share capital net of expenses

12 

2,897 

-

-

2,909 

Share based payment

-

462 

-

-

462 

Loss for the period

-

-

(2,890) 

(63) 

(2,953) 

Balance at 30 June 2008

246 

25,739 

(16,652) 

57 

9,390 

Balance at 1 January 2009

 246 

 25,802 

(18,829)

 8 

 7,227 

Share based payment

-

 112 

(157)

-

(45)

Loss for the period

-

-

(1,388)

 53 

(1,335)

Balance at 30 June 2009

 246 

 25,914 

(20,374)

 61 

 5,847 

5. Board

The financial information for the period 1 January 2009 to 30 June 2009 is unaudited although it has been reviewed by the Company's audit committee. In the opinion of the Directors the financial information for this period presents fairly the position, results of operations and cash flows for the period. The interim report for the six months ended 30 June 2009 was approved by the Directors on 23 September 2009.

 

6. Interim Results Statement

Copies of this Interim Results statement may be obtained by contacting the Company at Via di Lavoria 56 G, 56040 Crespina (PI), Italy. Alternatively the statement is available to download from the investor relations section on the Company's website www.acta-nanotech.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR EAKNDADDNEFE

Related Shares:

ACTA.L
FTSE 100 Latest
Value8,809.74
Change53.53